Remembrane isproud to announce that the Company was awarded the PERMIDES grant (http://permides.eu/)together with its international partner.

PERMIDESis one out of five European INNOSUP-1-2015 – Cluster facilitated projects fornew value chains projects (funded under EC Call for proposal:H2020-INNOSUP-2015-1).

Itis the aim of PERMIDES to strengthen the competitiveness and foster theinnovation potential of Personalized Medicine as an Emerging Industry in Europeby providing key solutions for the reconfiguration of the biopharmaceuticalvalue chain towards a Health Economy 4.0.

Remembrane thanks its partner and looks forward to this upcoming excitingcollaboration.